STAT4 and hepatocellular carcinoma: The results suggest that FGL2 might be downstream of CYP2E1 in the STAT4/CYP2E1 pathway and that STAT4 affects the occurrence and progression of HCC via regulation of the CYP2E1/FGL2 pathway.